RYTHM, Inc.
For the period ended Dec 31, 2024. Filed Mar 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 21, 2025
RYM$16.43-3.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net loss attributable to Agrify Corporation | $(41,746) | $(18,649) |
| Adjustments to reconcile net loss attributable to Agrify Corporation to net cash and cash equivalents used in operating activities: | ||
| Depreciation and amortization | 1,421 | 1,896 |
| Amortization of debt premium | (47) | (109) |
| Amortization of debt issuance costs | — | 24 |
| Stock-based compensation expense | 1,165 | 2,662 |
| Change in fair value of warrant liabilities | 17,902 | (4,695) |
| Loss on extinguishment of long-term debt, net | — | 4,311 |
| Change in provision for credit losses, net | (336) | (15,261) |
| Change in provision for inventory | (747) | (14,823) |
| Loss on abandonment of CIP projects | 31 | — |
| (Gain) loss on disposal of property and equipment | 14 | (63) |
| Gain on early termination of lease | (50) | — |
| Gain on settlement of contingent liability | (5,935) | — |
| Loss on disposal of Cultivation business | 11,893 | — |
| Change in contingent consideration | (2,180) | — |
| Income attributable to non-controlling interests | — | (1) |
| Changes in operating assets and liabilities, net of acquisitions: | ||
| Accounts receivable | 646 | 1,347 |
| Inventory | 8,341 | 17,158 |
| Prepaid expenses and other current assets | 1,872 | (566) |
| Operating lease right-of-use assets | 528 | 954 |
| Other non-current assets | 46 | 170 |
| Accounts payable | (4,562) | 108 |
| Accrued expenses and other current liabilities | 1,258 | (4,473) |
| Operating lease liabilities | (519) | (872) |
| Contract liabilities | (578) | (93) |
| Net cash and cash equivalents used in operating activities | (11,583) | (30,975) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (4) | (59) |
| Proceeds from disposal of property and equipment | 20 | 311 |
| Proceeds from sale of marketable securities | — | 10,461 |
| Issuance of loans receivable | (400) | (591) |
| Proceeds from repayment of loan receivable | 330 | 15,057 |
| Net cash and cash equivalents (used in) provided by investing activities | (54) | 25,179 |
| Cash flows from financing activities: | ||
| Proceeds from issuance of Common Stock through an S-1 and Pre-Funded Warrants offering | 2,123 | — |
| Proceeds from issuance of Common Stock through an “at the market” offering, net of fees | — | 1,545 |
| Proceeds from issuance of Common Stock through IONIC Stock Subscription | 345 | — |
| Proceeds from the issuance of Common Stock in connection with private placement, net | 25,793 | — |
| Proceeds from Employee Stock Purchase Plan Shares | — | 25 |
| Proceeds from exercise of Pre-Funded Warrants | 36 | — |
| Proceeds from issuance of warrants in settlement agreement | — | 1,554 |
| Proceeds from issuance of related party notes | 14,453 | 4,444 |
| Repayments of notes payable, other | — | (71) |
| Repayment of debt in private placement | — | (10,307) |
| Payments on other financing loans | — | (5) |
| Payments on insurance financing loans | (377) | (1,332) |
| Payments of financing leases | — | (80) |
| Net cash and cash equivalents provided by (used in) financing activities continuing operations | 42,373 | (4,227) |
| Net increase (decrease) in cash and cash equivalents | 30,736 | (10,023) |
| Cash and cash equivalents at the beginning of period | 434 | 10,457 |
| Cash and cash equivalents of discontinued operations, beginning of period | — | — |
| Cash and cash equivalents of discontinued operations, end of period | — | — |
| Cash and cash equivalents at the end of period | $31,170 | $434 |
| Supplemental disclosures | ||
| Cash paid for interest | $— | $76 |
| Supplemental disclosure of non-cash investing and financing activities | ||
| Fair value of warrants in connection with reclassification and issuance | $6,791 | $5,432 |
| Financing of prepaid insurance | $14 | $1,694 |
| Cashless exercise of liability classified warrants | $1,680 | $— |
| Conversion of related party debt to equity | $10,044 | $— |
| Transfer of property and equipment to inventory | $— | $33 |
| Conversion of liability classified pre-funded warrants to equity | $20,771 | $— |
| Deemed contribution from troubled debt restructuring with related party | $676 | $— |
| Stock and warrants issued in connection with business combination | $18,836 | $— |
| Conversion of convertible notes into equity | $1,731 | $3,306 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.